# Differential Leucocyte Count and Covid-19 Diagnosis

> **NCT04643860** · — · WITHDRAWN · sponsor: **Neuromed IRCCS**

## Conditions studied

- SARS-CoV-2 Infection Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Differential Leucocyte Count (CLDC) device and algorithm

## Key facts

- **NCT ID:** NCT04643860
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-15
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients arruoled
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04643860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04643860, "Differential Leucocyte Count and Covid-19 Diagnosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04643860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*